Navigation Links
Block Engineering Announces Collaborative Agreement with Pfizer for Next Generation Cleaning Verification Technology
Date:1/18/2013

MARLBOROUGH, Mass., Jan. 18, 2013 /PRNewswire/ -- Block Engineering, the leader in Quantum Cascade Laser (QCL) spectroscopy, announced today that it has signed a Collaborative Agreement with Pfizer, Inc. to develop a QCL-based system for real-time, noncontact Cleaning Verification of vessels during pharmaceutical manufacturing. The technology is based on Block's commercially available LaserScan (TM) Analyzer, which will be tailored to address the specific requirements of this application.

Accurate Cleaning Verification of vessels has a significant impact in pharmaceutical manufacturing, due to the potential health risks of cross-contamination between products. Today, in order to ensure that the walls of these vessels meet tough FDA cleanliness standards, swab-based techniques are applied to collect samples and bring them to off-line instruments, such as High Pressure Liquid Chromatography (HPLC) systems. These measurements typically take several hours or more per vessel during which the vessel usually remains idle. The key value proposition of the proposed technology is to eliminate this bottleneck and provide a handheld, battery-operated, barcode-scanner-like device capable of providing real-time, noncontact verification of the cleanliness of the vessel walls. Using the proposed technology, pharmaceutical manufacturing equipment could be scanned in a matter of minutes and potential areas that require additional cleaning will be identified in real-time without the need to take any samples. Block's device requires no consumables and utilizes next generation, eye-safe QCL-based infrared spectroscopy.

"Cleaning Verification is a critical step in the drug manufacturing process and Pfizer is committed to the development of technologies that could decrease inspection times, reduce costs and improve supply assurance," said Steve Hammond , Head of the Process Analytical Sciences Group (PASG) and Senior Director in the Global Manufacturing Services organization at Pfizer. "Block's groundbreaking technology fits well within Pfizer's Process Analytical Technology (PAT) initiatives and I look forward to working with them towards the development of this instrument."

The expected benefits of this novel approach include a reduction in the labor, material and consumables required today for swab-based verification. Furthermore, significant plant utilization increases can be achieved and drug supply assurances can be confidently offered. Key initiatives in the pharmaceutical industry today for Work-in-Progress inventory reduction and just-in-time-inventory implementation will significantly benefit from the proposed technology, as the manufacturing equipment idle time is reduced.

Petros Kotidis , CEO of Block Engineering commented, "I am very pleased to announce the strategic agreement with Pfizer towards the development of this breakthrough instrumentation. Block's QCL-based infrared spectrometers are opening new markets and Cleaning Verification is one of the most exciting and high impact applications. Pfizer's dominant and pioneering position in the introduction of next generation process analytical technologies will be a critical element in the success of this product."

The fundamental principle behind Block's technology and the currently commercially available LaserScan Analyzer is QCL-based infrared spectroscopy. When infrared light from the QCL reflects off of substances, it gets absorbed or reflected at rates that are absolutely unique to and characteristic of the substance. Therefore, when the reflected light is collected by the LaserScan's built-in detectors, a "fingerprint"-like pattern emerges, which contains all the necessary information for detection or analysis of the substance. Built-in libraries are typically used to pattern and provide real-time detection or analysis. Block's devices use unique QCLs, which cover the widest spectral range in the world within the 5-14 micron range and provide rapid sub-second, real-time measurements in handheld configurations.

About Block Engineering, LLC:
Founded in 1956, Block Engineering, LLC is a leading manufacturer and marketer of high performance Quantum Cascade Laser (QCL) and FTIR spectrometers for commercial, industrial, military and government customers. Block's Mobile Chemical Agent Detector (MCAD) system is a fixed site, passive FTIR spectrometer offered in partnership with Northrop Grumman Corp.  Block's PORTHOS (TM) is a portable, passive FTIR spectrometer system that remotely detects chemical threats as far as three miles and protects against chemical warfare agents and weapons of mass destruction. Block Engineering is also manufacturing and selling a line of unique QCL-based spectrometers, including the LaserScan Analyzer, for applications ranging from detection of explosives and liquid/solid chemical warfare agents to control of manufacturing operations and verification of surface conditions in a variety of industrial processes.

Block Engineering is located in Marlborough, Massachusetts, USA. For more information, visit www.blockeng.com.

Contact: Scott Riggi , Vice President of Sales, 508-251-3105, scott.riggi@blockeng.com

This release was issued through The Xpress Press News Service, merging e-mail and satellite distribution technologies to reach business analysts and media outlets worldwide. For more information, visit http://www.XpressPress.com.

 


'/>"/>
SOURCE Block Engineering
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Zenobia Therapeutics, Inc. And BioBlocks, Inc. Announce Sale Of A Joint Fragment Library Ideal For Screening By All Popular Methods
2. Frost & Sullivan: European Bipolar Therapeutics Market Slows Down in the Short Term As Key Blockbuster Drugs Go Off Patent
3. Block Engineering Partners with SKAE and Pembroke for Quantum Cascade Laser Instrument Sales
4. Abbott Sued for False Claims Related to its Blockbuster Drug TriCor
5. Kentuckys PSE Blocking Technology Leading To Progress In Battle Against Meth
6. Missouris PSE Blocking Technology Leading To Progress In Battle Against Meth
7. Austen BioInnovation Institute in Akron Attracts Nationally Known Speakers For Conference on Value-driven Engineering, April 23-24
8. Nearly 300 Medical Device, Healthcare Professionals Attend First National Conference on Value-driven Engineering
9. Swiss Engineering for Surgical Perfection
10. American Oriental Bioengineering Inc. Announces Suspension of Trading in its Common Stock and the Initiation of Delisting Proceedings by NYSE
11. American Oriental Bioengineering Announces Change of Independent Auditors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... 20, 2017  RXi Pharmaceuticals Corporation (NASDAQ: RXII), ... address significant unmet medical needs, today announced that ... consumer product development program, based on its proprietary ... Investigative Dermatology (SID) 76 th Annual Meeting.  ... the sciences relevant to skin health and disease ...
(Date:4/20/2017)... 20, 2017   ZappRx, Inc ., a digital health ... process, today announced it closed $25 million in Series B ... firm based in Seattle that is ... . The Series B round included participation from SR ... and GV (formerly Google Ventures). As part of ...
(Date:4/20/2017)... -- Eyevensys, a private biotechnology company developing ... technology that enables the safe, local, sustained production of ... range of ophthalmic diseases, announces it has received approval ... (MHRA) to advance its technology into clinical development. ... The EyeCET platform ...
Breaking Medicine Technology:
(Date:4/28/2017)... , ... April 28, 2017 , ... ... announce the integration of Microsoft(R) Word(TM) Online(TM), which enables sleep physicians to create ... it streamlines the reporting process and provides a familiar interface that does not ...
(Date:4/28/2017)... ... ... sleep affects much more than energy – it also has mental and physical benefits. According ... reaction time, which can increase the risk of having a car accident. , This ... NSF to help you sleep better and feel better:, , Turn ...
(Date:4/28/2017)... ... April 28, 2017 , ... Ushio America proudly ... offer an instant energy-saving solution for F32T8 fluorescent lamps on most instant-start and ... These 50,000 hour rated lamps utilize the existing electronic ballast, saving labor and ...
(Date:4/28/2017)... ... April 28, 2017 , ... ... exposed to more adverse experiences than children in the general population. That’s because ... abuse, neglect or other family challenges. While no fault of their own, youth ...
(Date:4/28/2017)... ... April 28, 2017 , ... Early detection ... improve drug safety and minimize the cost of development. In this webinar, sponsored ... using cell lines and for cardiac toxicity using induced pluripotent stem cells (iPSCs). ...
Breaking Medicine News(10 mins):